NDATOPICALOINTMENT
Approved
Dec 1987
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Clinical Trials
2
Mechanism of Action
CLINICAL PHARMACOLOGY Pharmacokinetics Following single or repeated intranasal applications of 0.2 gram of BACTROBAN NASAL 3 times daily for 3 days to 5 healthy adult male subjects, no evidence of systemic absorption of mupirocin was demonstrated. The dosage regimen used in this study was for…
Clinical Trials (2)
Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection
Started Sep 2003
100 enrolled
Staphylococcus AureusHIV Infections
Prophylaxis With Intranasal Mupirocin for Prevention of S. Aureus Infections
Started Nov 2002
1,200 enrolled
Cross InfectionStaphylococcal Infections